Steve Schonfeld’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-53,197
Closed -$976K 2581
2026
Q1
$976K Buy
+53,197
New +$1.01M 0.01% 1108
2025
Q4
Sell
-55,787
Closed -$1.08M 2024
2025
Q3
$1.08M Sell
55,787
-32,215
-37% -$629K 0.01% 1325
2025
Q2
$1.82M Buy
88,002
+58,512
+198% +$1.22M 0.01% 1036
2025
Q1
$721K Sell
29,490
-5,201
-15% -$134K ﹤0.01% 1426
2024
Q4
$830K Sell
34,691
-25,839
-43% -$821K ﹤0.01% 1198
2024
Q3
$2.57M Buy
+60,530
New +$3.17M 0.02% 779
2024
Q2
Sell
-17,609
Closed -$1.1M 2123
2024
Q1
$1.1M Sell
17,609
-5,691
-24% -$387K 0.01% 1190
2023
Q4
$1.74M Buy
+23,300
New +$1.67M 0.01% 846
2023
Q3
Sell
-4,794
Closed -$523K 1748
2023
Q2
$523K Sell
4,794
-23,787
-83% -$2.26M ﹤0.01% 1206
2023
Q1
$2.37M Buy
+28,581
New +$2.69M 0.02% 647
2022
Q4
Sell
-14,084
Closed -$1.49M 2565
2022
Q3
$1.49M Buy
14,084
+13,984
+13,984% +$1.53M 0.01% 1026
2022
Q2
$11K Buy
+100
New +$9.9K ﹤0.01% 2303
2020
Q2
Sell
-5,172
Closed -$299K 1221
2020
Q1
$299K Buy
+5,172
New +$354K 0.02% 752
2016
Q4
Sell
-20,408
Closed -$650K 539
2016
Q3
$650K Buy
+20,408
New +$775K 0.11% 237

Other funds holding AMN

Steve Schonfeld's AMN Position: Q2 2026 in Review

Steve Schonfeld sold out of AMN Healthcare (AMN) in Q2 2026, closing a stake of 53,197 shares — an estimated $976K sold.

Steve Schonfeld first reported a position in AMN in Q3 2016 and held it in 14 quarters. The position peaked at $2.57M in Q3 2024. 283 funds tracked by Wall St. Rank hold AMN as of Q2 2026.

  • Steve Schonfeld reported no remaining AMN Healthcare position as of Q2 2026 after selling out during the quarter.
  • Steve Schonfeld sold 53,197 AMN Healthcare shares in Q2 2026, an estimated $976K.
  • Steve Schonfeld first reported a position in AMN Healthcare in Q3 2016 and held it in 14 quarters.
  • Steve Schonfeld's AMN Healthcare position peaked at $2.57M in Q3 2024.
  • 283 funds tracked by Wall St. Rank held AMN Healthcare as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.